There is a mesencephalic dopaminergic network outside the ventral tegmental area (VTA), including structures such as the rostral linear nucleus (RLi) and periaqueductal gray (PAG). These nuclei project to neural areas implicated in reinforcing effects of drugs, indicating that they could participate in opiate reward. The objectives were to study the morphological characteristics of the dopamine network of the RLi/PAG region, and to discern its role on rewarding and sensitizing effects of heroin in rats, following dopamine depletion or local injection of dopaminergic antagonists. The findings indicated that this network is composed of small cells in the RLi/ventral PAG, large multipolar dopamine PAG neurons, and periaqueductal PAG neurons. Following repeated heroin, large PAG neurons and small RLi/ ventral PAG cells (not periaqueductal neurons) were activated, since tyrosine-hydroxylase was adaptively induced, without changes in protein kinase Aa. After dopamine depletion, small RLi/ventral PAG neurons and large cells of the PAG (not periaqueductal ones) were selectively affected by the neurotoxin. Dopamine neurons of the nearby VTA and dorsal raphe were not affected, as revealed by cell counting. After lesion, 'anxiety-like' responses and basal locomotion were not altered. However, conditioned place preference to heroin was found to be abolished, as well as heroin-induced motor sensitization. Following infusions of dopaminergic antagonists into RLi/PAG, D 2 (not D 1 ) receptor blocking dose-dependently abolished heroin-induced reward. The present study provides evidence that dopamine neurons of the RLi/PAG region (excluding PAG periaqueductal cells) show adaptive biochemical changes after heroin, and mediate the rewarding and sensitizing effects of this drug. D 2 dopamine receptors within the RLi/PAG region participate in these effects.
INTRODUCTION
There is a continuous network of dopaminergic neurons that extends throughout the mesencephalon, including neurons within the ventral tegmental area (VTA, A10 area), the rostral linear nucleus (RLi), the periaqueductal gray (PAG), and dorsal raphe (DR). The PAG/DR network is also termed the dorsocaudal A10 group (A10dc) (Hökfelt et al, 1984; Hasue and Shammah-Lagnado, 2002) . Figure 1 shows representative mesencephalic sections including those nuclei with dopaminergic neurons. The VTA is considered as a critical region for rewarding properties of drugs of abuse, but the role of adjacent dopaminergic areas is not well known.
The RLi nucleus is composed of small and rounded dopamine neurons, and is considered as independent to the VTA (Phillipson, 1979) although some authors incorporate it to this area (Oades and Halliday, 1987) . The dopaminergic network of the PAG is composed of small and large neurons (Hasue and Shammah-Lagnado, 2002) . Dopamine neurons of the RLi/PAG region project locally or onto different brain structures such as the central amygdaloid nucleus, bed nucleus of the stria terminalis, sublenticular extended amygdala, and substantia innominata (Ottersen, 1981; Grove, 1988; Hasue and Shammah-Lagnado, 2002) . These neural areas are of relevance for drug reward, particularly the central amygdaloid nucleus and extended amygdala (Wise, 1989; Caine et al, 1995; Di Chiara et al, 1999; Nestler, 2001) . Considering these connections and the key role of dopamine on drug reward, RLi and PAG could participate in opiate reward. Besides, the number of amygdalopetal dopaminergic fibers arising from the PAG (and DR) is the same that those arising from A8, A9, and VTA-A10 groups together (Hasue and Shammah-Lagnado, 2002) , and RLi/ PAG tyrosine hydroxylase TH + efferents course in the VTA and medial forebrain bundle (MFB) suggesting that they could also be affected after VTA and MFB dopaminergic lesions and participate in functional changes reported by different authors (Vertes, 1991) .
Addictive effects of opiates can be evaluated through either conditioned place preference (CPP, an index of the incentive value of the drug) or locomotor sensitization. The latter is the enhancement in the motor stimulant effects elicited by repeated drug administration (Stewart and Badiani, 1993; Vanderschuren and Kalivas, 2000; Nestler, 2001) , and neural and biochemical adaptations that result in sensitization in animal models are likely the same which result in some forms of addictive behavior in humans (Robinson and Berridge, 1993; Carlezon et al, 1997; Nestler and Aghajanian, 1997; Messer et al, 2000; Nestler, 2001) . It is widely accepted that repeated opiate exposure is linked to biochemical traits in several mesolimbic regions, such as increase of TH in the VTA or protein kinase Aa (PKAa) upregulation in the nucleus accumbens (Terwilliger et al, 1991; Beitner-Johnson and Nestler, 1991; Brodkin et al, 1999) . TH upregulation seems to be linked to augmented dopamine neurotransmission in the VTA and terminal regions such as the nucleus accumbens (BeitnerJohnson and Nestler, 1991; Sklair-Tavron et al, 1996) , and heightened dopaminergic neurotransmission is thought to trigger the induction of transient immediate early genes, and more enduring transcription factors implicated in morphine's motor sensitization and reward (Nye and Nestler, 1996; Segal and Kuczenski, 1992; . Activation of accumbal PKA has been shown to be critical for the motor-sensitizing effects of drugs of abuse (Cunningham and Kelley, 1993; Miserendino and Nestler, 1995) . These biochemical changes could also take place in the RLi/PAG region after opiates. The objectives of this study were: (i) to further describe the morphological characteristics of the dopaminergic network extended throughout the RLi/PAG region, (ii) to discern if these dopaminergic cells are activated after repeated heroin administration (as measured through TH and PKAa expression), (iii) to establish the effects of selective lesions of the DA neurons of RLi/ PAG region on heroin-induced reward (as measured through CPP) and locomotor sensitization, and (iv) to discern the role of D 1 and D 2 dopamine receptors within RLi/PAG on heroin-mediated effects.
MATERIALS AND METHODS

Animals and Experimental Protocol
Male Wistar rats (275-325 g) from the breeding colony of the Faculty of Medicine of the University of Seville, Spain, were used. Laboratory temperature was kept at 22711C, and a 12-h light-dark cycle (lights on at 0800 h) was 
Experiment 1
The morphology of the dopaminergic network of the RLi/ PAG region was studied in normal rats.
Immunohistochemistry and immunofluorescence. Naïve rats were killed by decapitation and brains carefully removed (n ¼ 10). After dissection, brains were stored in 4% paraformaldehyde in phosphate buffer (PB) 0.1 M (pH 7.2-7.4) at 41C, and later immersed overnight in 25% sucrose in PBS for cryoprotection before sectioning. Coronal brain sections (30 mm thick) were cut on a cryostat and collected in PBS. Thereafter, endogenous peroxidase activity was quenched by placing sections into 0.3% H 2 O 2 in 0.05 Tris buffer (pH ¼ 7.6) for 2 h. Then sections were incubated in PBS/0.1% Triton X-100 (PBS-T) with 10% FCS (Vector, USA) and BSA (1 mg/mgl, Sigma, USA) for 4 h to block nonspecific binding sites. Sections were incubated overnight with mouse anti-tyrosine-hydroxylase (TH) monoclonal antibody (anti-TH, 1 : 1000, Sigma, USA) and rabbit anti-dopamine-b-hydroxylase (DBH) antibody (1 : 1000, Diasorin, Spain) in PBS-T, and, after washing in PBS-T, they were incubated for 10 h with anti-mouse or anti-rabbit biotin-conjugated antibody (1 : 200, Chemicon, USA). Then, sections were incubated with the ABC kit (1 : 100, Pierce, USA) for 2 h, and specifically bound antibody was revealed by using 3.3 0 -diaminobencidine tetrahydrochloride (DAB, Sigma, USA) as chromogen, and 0.05% hydrogen peroxide (Merck). Control sections were incubated in the same solutions for the same incubation times as the other brain sections, with the exception that the primary antibody solution was replaced by a PBS-T solution containing 10% FCS and BSA (1 mg/ml) without the primary antibody. Sections were washed in PBS and mounted on glass slides and coverslipped with DPX. For immunofluorescence, sections were incubated overnight with rabbit anti-TH (1 : 1000, Chemicon, USA), and mouse anti-NeuN monoclonal antibody (1 : 1000, Chemicon, Spain) in PBS-T, and, after washing in PBS-T, they were incubated for 10 h with anti-mouse fluorescein-conjugated (1 : 500, Pierce, USA) and anti-rabbit rhodamine-conjugated antibody (1 : 1000, Pierce, USA). Sections were washed in PBS and mounted on glass slides and coverslipped with 50% glycerol/50% PBS.
Stereological methods. Volumetric measurements were carried out by applying the principle of Cavalieri, using photo sections (Lagares and Avendaño, 1999) . Every five coronal sections (50 mm width, t ¼ 200 mm) of the mesencephalus including the VTA and the RLi/PAG region were randomly sampled by using a reticle of hitting points, where the area associated with each sampling point was 0.11 mm 3 (a(p)). The estimate of the volume was calculated as V ¼ t : aðpÞ : SPi, where SPi ¼ total number of hitting points. The coefficient of error was calculated according to a formula which takes into account the shape of the organ (e.g. 3.8 for an irregular prismatic-like structure such as the RLi/PAG region; Gundersen and Jensen, 1987) . The number of TH + cells was calculated applying the physical disector method (Sterio, 1984) . For this procedure, six systematically chosen pairs of adjacent sections ð t ¼ 200 mmÞ were used. Four disector frames were used for every section, and the area of the disector frame covered 16,104 mm 2 (a(ret)). The estimated disector volume or SV(dis) was calculated as SV(dis) ¼ number of disectors t. a(ret). The estimate of the number of cells (N) was calculated as
, where SQ À was the total number of cells counted in all the disectors, and V(ref) was the estimate of the volume of the studied region, as measured by the principle of Cavalieri.
Experiment 2
Saline or heroin were administered daily during 3 days (heroin, 500 mg/kg s.c.). Rats were killed 2 h after the last heroin administration, for studying TH and PKAa expression in the RLi/PAG region, both known markers for biochemical adaptations to opiates.
Immunohistochemistry and measurement of TH + neuronal density in the RLi/PAG region. Immunohistochemistry was performed as explained before (saline, n ¼ 6; heroin, n ¼ 6). The optical density of TH + large and small neurons of the RLi/PAG region was measured at four different rostrocaudal levels corresponding to À5, À5.3, À5.6, and À6 mm relative to bregma (Paxinos and Watson, 1997) . Images of coronal sections were taken with a high-resolution digital camera from a microscope equipped with a natural density filter to give constant illumination throughout the specimen. The digitalized images were analyzed using Scion Image for PC. Optical density readings were corrected for background staining (commissure superior colliculi, a nondopaminergic region of the tissue). All values are expressed as percent of the background staining for each section.
Western blotting. Brains were removed from decapitated rats (saline, n ¼ 6; heroin, n ¼ 6) and cooled in ice-cold physiological buffer. The RLi/PAG region was obtained by careful dissection of the region under microscope observation, according to the Paxinos and Watson's atlas (1997) . Brain samples were lysated in 10% glycerol, 137 mM NaCl, and 20 mM Tris HCl, pH 7.5, containing peptidases (1 mg/ml aproteinin and leupeptin, 1 mM PMSF). Protein levels were quantified by using the Bradford method. Samples were boiled and aliquots containing 25 mg of protein each were subjected to SDS/polyacrylamide gel electrophoresis. Proteins were transferred electrophoretically to PVDF membranes, which were the blocked with 2% nonfat dry milk in TTBS, pH 7.5 (5 M NaCl, 2% 1 M Tris-HCL, 0.05% Tween 20). Immunolabelling was conducted for TH with mouse monoclonal anti-TH antibody (1 : 1000, Sigma), PKAa with rabbit polyclonal anti-PKAa antibody (Santa Cruz, USA), and a-tubulin (control protein) with mouse monoclonal anti-a-tubulin antibody (Santa Cruz). Primary antibodies were detected with peroxidase-linked secondary antibodies (Santa Cruz) and with enhanced chemiluminescence (ECL) (Amersham, USA), and autoradiography. Band densities of resulting autoradiograms were quantified by using the Scion Image for PC (NIH, USA).
Statistics. Density values of TH + immunosignal and of blot bands were compared with the nonparametric MannWhitney U-test.
Experiment 3
The effects of 6-hydroxydopamine (6-OHDA)-induced lesion of the RLi/PAG region on heroin's CPP and motor sensitization were studied. Possible behavioral deficits ('anxiety-like' and locomotor responses) resulting from 6-OHDA-induced lesion of the RLi/PAG were also studied.
6-hydroxydopamine-induced lesion of the RLi/PAG region. At 30 min before 6-OHDA (RBI) lesion, rats were injected with the antibiotic ceftriazone (10 mg/0.3 ml i.m.), as well as with desipramine (15 mg/kg i.p.) and citalopram (2 mg/kg i.p.) in order to protect noradrenergic and serotonergic fibers from 6-OHDA toxicity, respectively. Rats were anesthetized with ketamine (50 mg/kg i.m.) and xylazine (10 mg/kg i.m.), and placed in a Kopf stereotaxic apparatus with the incisor bar set 3.3 mm below the interaural line. Saline solution (0.3 ml per site) containing 6-OHDA (5 mg/ml) and 0.2% ascorbic acid was injected over 5 min with a blunted 30-gauge cannula at the following coordinates with respect to bregma: AP ¼ À5.6, L ¼ 70.5, and V ¼ À5.5 (Paxinos and Watson, 1997) . The cannula was left in place for 1 min after injection. Control rats followed the same protocol, except that a 6-OHDA-free solution (0.9% NaCl and 0.2% ascorbic acid) was injected. Rats were allowed 1 week to recover after surgery before experimental tests began.
'Anxiety-like' and open-field tests. In order to address whether there are behavioral deficits resulting from 6-OHDA-induced lesion of the RLi/PAG that could mask or interfere CPP and motor sensitization results, 'anxietylike' and basal locomotor responses were studied in all lesioned and sham rats (n ¼ 28 each group). 'Anxiety-like' behaviors were analyzed by using the light-dark and elevated plus-maze tests, two animal models of anxiety. The light-dark apparatus consisted of a two-compartment rectangular box made up of Plexiglas, with one compartment painted white (30 Â 48 Â 34 cm high) and illuminated by a 60-W white incandescent bulb (900 lux) and the other compartment painted black (30 Â 48 Â 34 cm high), without illumination. The two compartments were connected by an opening (9 Â 8 cm). Rats were placed in the light compartment at the beginning of the test, and several behavioral parameters were quantified over 5 min: time spent in light compartment, time spent in dark compartment, and number of transitions from dark to light (Espejo and Miñano, 1999) . Operational criterion for entry was whole body and four paws entry. (Rodgers and Cole, 1994; Espejo, 1997) . For each group of rats 'anxiety-like' behavior was studied 30 min after the administration of saline or the anxiolytic compound diazepam (2.5 mg/kg i.p.), in order to discern the basal 'anxiety-like' level, as well as if both groups of animals responded to an anxiolytic dose of diazepam (Finlay et al, 1995; Wilson et al, 2004) . Regarding tests, they were performed daily, and the light-dark test was carried out first. For each anxiety test, saline or diazepam was injected following a Latin-square design (half of the rats were injected with saline the first day of the test, and the other half were injected first with diazepam), in order to minimize the possible learning effects following test repetition. The first anxiety test was carried out 1 week after surgery.
At 2 days after the last elevated plus-maze test, locomotor activity was evaluated. Each rat was placed in an open field (1 Â 1 m) for 10 min, and distance travelled was quantified. Time spent on each light/dark compartment or closed/open arm as well as distance travelled were measured by using the automatized Smart system (Panlab, Spain). Behavior in the anxiety-like tests was also videotaped, and the number of transitions was scored 'blind' by a trained observer (intra rater reliability ¼ 0.9). All behavioral tests were carried out during the last phase of the light period (1800 to 2000 h).
Conditioned place preference. Half of the lesioned (n ¼ 14) and sham (n ¼ 14) rats were used for this study. The CPP apparatus used to evidence a reliable conditioned preference consisted of three rectangular boxes (40 Â 33 Â 34 cm) arranged radially (1201 to each other) and accessible from a triangular central section (Stinus et al, 1990; Schulteis et al, 1994; Caillé et al, 1999) . Distinctive visual and tactile cues distinguished the three compartments: the walls and floor coloring (yellow stripes, red squares and black stripes), and the room spatial cues, maintained in the same orientation every day. The set-up was placed in a sound-attenuated testing room, and illuminated by three 15 W white lights located 1.5 m above each compartment. The experimental protocol comprised three distinct phases: a preconditioning phase, a conditioning phase, and a testing phase.
In the preconditioning phase (day 1, 1 week after the open-field test), animals were placed in the central section and allowed to freely explore the apparatus for 30 min (1800 s). Animals showing strong unconditioned aversion (less than 120 s of the session time) or preference (more than 1680 s of the session time) for any compartment were discarded. For each rat, the two compartments with the closest time allotments were chosen. One was randomly chosen to be paired to the opiate drug and the other to the vehicle. The unassigned compartment could be either the most or the least preferred of the three. We checked after assigning the compartments that there were no significant differences between time spent in the drug-paired and the vehicle-paired compartments during the preconditioning phase. This is an important step in the experimental procedure which avoids any preference bias prior to conditioning. In the second phase (conditioning), rats received subcutaneous injection of vehicle saline and heroin on days 2-4 (morning, heroin; evening, saline), immediately prior to being confined for 30 min to their preselected vehicle-paired or drug-paired compartment, respectively (v/ w 1 ml/kg body weight). Heroin was injected at 100 and 500 mg/kg SC (n ¼ 7 each lesion or sham group). The testing phase consisted of two 30-min tests of free exploration of the entire apparatus on day 5 (one test in the morning, another in the evening), and the time spent in each compartment was calculated as the mean of both tests. In order to discard habituation of conditioning after repeated testing, time values of both postconditioning tests were compared. Since an unbiased protocol was used, CPP was calculated as time spent in the heroin-paired compartment compared to time spent in the saline-paired side during postconditioning. The preconditioning and postconditioning sessions were videotaped and later analyzed by using the SMART system for behavioral studies (Panlab, Spain), which allows calculating the exact time spent in each compartment.
Locomotor sensitization. Half of the lesioned (n ¼ 14) and sham (n ¼ 14) rats were used for this study. Rats were tested on 25 Â 25 cm cages, all animals receiving heroin (50 or 100 mg/kg s.c. daily; n ¼ 7 in each lesion or sham group) in the same environment, 1 week after the open-field test. Locomotor activity was recorded during 2 h starting immediately after heroin injection. Distance travelled (m) was measured by using the automatized SMART system. Heroin was injected daily during 5 days (induction phase), as well as at day 12 (expression phase). The first injection was preceded by 2 days of habituation, where rats were placed on the environment during 2 h without treatment, in order to avoid the effects of novelty on locomotor activity.
Immunohistochemistry, stereology, and statistics. Rats were killed after completion of behavioral study, 2 h after the last heroin administration. Immunohistochemistry for TH and stereological methods were performed as explained. The mean number of TH + neurons in the RLi/PAG and VTA regions in sham and lesioned rats were compared with the Student's t-test. This test was also employed for statistical comparisons between groups in 'anxiety-like' and open-field tests. For CPP, a three-way ANOVA was used (group and dose, between factors; compartment, within factor). Post-hoc comparisons between groups were carried out by using the Tukey's test. Regarding locomotor sensitization, a three-way ANOVA was used in search for significant interaction effects (day of treatment, within factor; group and heroin dose, between factors). Post-hoc Tukey's test was used for discerning statistical differences. When variance was not homogeneous, data were transformed (square [x] ) prior to analysis.
Experiment 4
The effects of local intra-RLi/PAG infusions of dopamine receptor antagonists on heroin's CPP and motor sensitization were studied.
Guide cannula surgery and intracranial injections. To study the intra-RLi/PAG effects of dopaminergic ligands, anesthetized rats were given prophylactic ceftriazone and placed in a Kopf stereotaxic apparatus. A hole was drilled over the injection site, and a 22-gauge stainless steel guide cannula (Small Parts. USA) was aimed 2 mm above the corresponding infusion site: AP ¼ À5.6, L ¼ + 2, and V ¼ À5.5 mm vs bregma. The cannula was introduced with an angle of 301 vs the vertical axis to avoid the sinus vein to be damaged. The guide cannula was fastened to the skull with stainless steel screws (Small Parts, USA) and dental cement, and was fitted with a 30-gauge stainless steel obturator, protruding 2 mm out of the tip of the guide cannula (Small Parts). Rats were allowed to recover 1 week after surgery. Injections (0.5 ml each) were performed in the home cage after removing the obturator cannula, that was replaced by a 30-gauge stainless steel internal cannula (Small Parts, USA) connected to a Hamilton syringe and a delivery pump (Stoelting, Germany). Solutions were slowly injected over 5 min, and then the internal cannula was carefully removed 1 min later and the obturator cannula was replaced.
An additional group of 10 rats received cannulae targeted outside the RLi/PAG region (1.5 mm distant from the ventrolateral PAG), in the central tegmental tract, as an anatomical control group. Thus, the stainless steel guide cannula was aimed 2 mm above the corresponding infusion site: AP ¼ À5.6, L ¼ + 2, and V ¼ À4.5 mm vs bregma (at the level of the central tegmental tract, Paxinos and Watson, 1997) . The guide cannulae for extra-RLi/PAG region placements made trajectories through the cortex similar to cannulae for RLi/PAG sites. This group of rats served for studying the effects of injections in the dorsal vicinity of the RLi/PAG region in order to discard the emergence of behavioral effects due to diffusion of injected solution. After completion of all the experiments, rats' brains were removed and sectioned. Sections were stained by using the Nissl method, and then cannula placements were verified under a microscope, mapped onto a stereotaxic atlas (Paxinos and Watson, 1997) , and confirmed to be in the RLi/PAG region or in the central tegmental tract.
CPP and dopaminergic ligands. CPP was carried out as explained. Saline or heroin sulfate (500 mg/kg) was injected s.c. immediately before rats were placed on the corresponding compartment (v/w 1 ml/kg body weight). Dopaminergic ligands were infused 10 min before heroin injection. Two dopamine receptor antagonists, SCH 23390 (D 1 dopamine receptor antagonist, Tocris) and eticlopride (D 2 dopamine receptor antagonist, RBI, USA), were used. SCH-23390 was injected at 0, 1, and 2 mg/ml doses (free-base, 0, 4.6, and 9.1 nmol, n ¼ 7 in each dose group), and eticlopride was administered at 0, 0.5, and 1 mg/ml doses (free-base, 0, 2.6, and 5.3 nmol, n ¼ 7-each dose group). SCH 23390 was dissolved in double-distilled water, and eticlopride was dissolved in 30% ethanol/70% distilled water. The corresponding vehicle was used for the control group in every treatment.
Statistics. For CPP, two-way ANOVA was used (dopaminergic ligand dose, between factor; compartment, within factor). Post-hoc comparisons between groups were carried out by using the Tukey's test. When variance was not homogeneous, data were transformed (square[x]) prior to analysis.
RESULTS
Experiment 1
Dopamine cells of the RLi/PAG region. Following immunolabelling for TH, the morphological study revealed that, as measured through the principle of Cavalieri, the estimate of the volume of the RLi/PAG region was 0.7470.09 mm 3 (mean7SEM). TH + neurons were found to be scattered throughout the RLi and ventrolateral PAG (Figure 2 ). Detailed microscopical observation of TH + cells allowed classifying them into three groups depending on their size and location, as observed in Figure 2a -f: (i) small rounded neurons (10 mm in diameter) scattered throughout the ventral PAG and RLi nucleus, where no boundaries between both nuclei could be observed and hence they are referred to as neurons of the RLi/vPAG (Figure 2a ,b, and e); (ii) large size cells of the PAG (30-50 mm in diameter) located in the ventrolateral region of the PAG, with a multipolar morphology, and giving rise to abundant fibers with regularly spaced varicosities ( Figure 2a-d) ; and (iii) periaqueductal neurons of the PAG: rounded neurons of diameter 15 mm located adjacent to the aqueduct of Sylvius surface (Figure 2a-c, f) . At the most caudal levels, large TH + cells of the PAG disappeared and only periaqueductal PAG cells could be observed, together with small rounded neurons of the DR (Figure 2g ). The estimate of the mean number of each cell type was: 1441.47210 small size cells of the RLi/vPAG, 129.4731.3 large size cells of the PAG, and 305.8743.5 periaqueductal neurons of the PAG, as measured with the disector method. Numerous TH + fibers were detected running within the RLi/PAG region, mostly in the ventrolateral part of the PAG, with regularly spaced varicosities (Figure 2b-d) . In order to confirm that TH + cells were neurons, double immunofluorescent labelling of NeuN (neuronal marker) and TH was performed, indicating that all TH + cells were NeuN + (Figure 2h, i) . As shown in Figure 2j , immunolabelling for DBH, the noradrenaline synthesizing enzyme, indicated that no DBH + cells were observed in RLi/PAG, revealing that these neurons were dopaminergics. A control immunostaining study of the locus coeruleus (noradrenergic center) revealed that this nucleus contained DBH + cells as expected (data not shown).
Experiment 2
Dopamine neurons of the RLi/PAG, except periaqueductal PAG cells, show enhanced TH expression after repeated heroin treatment. Following a 3-day treatment with saline or 500 mg/kg heroin s.c., density measurement of TH signal revealed that TH + density of periaqueductal PAG neurons was not affected by heroin treatment, but a significant enhancement was observed in large PAG neurons (U ¼ 2, po0.01), and small RLi/vPAG dopamine neurons (U ¼ 2.2, po0.01), as shown in Table 1 . This fact indicates that TH expression was induced in TH + neurons of the RLi/PAG region after repeated heroin treatment, except for periaqueductal ones. Western blotting also indicated that TH expression of the whole RLi/PAG region was upregulated after 3-day treatment with heroin. Thus, density of blot bands was significantly enhanced in opiate-treated rats vs lesioned animals (po0.01), as shown in Figure 3 . No differences in the expression of PKAa were indicated by immunoblots. The immunoblot bands of a-tubulin (control protein) indicated that similar amounts of protein were loaded.
Experiment 3
Dopamine depletion of the RLi/PAG region: morphology. After 6-OHDA infusions into the RLi/PAG region, the number of large TH + PAG cells and small RLi/vPAG neurons was reliably reduced by 61.973.4% (large PAG neurons, t ¼ 3.5, po0.01) and 68.474% (RLi/vPAG neurons, t ¼ 4.1, po0.01 vs sham normal), respectively, as observed in Figure 4a -e. Every lesioned rat presented a decreased number of these neurons higher than 55% vs sham. The mean number of large PAG neurons was reduced from 306743 in sham rats to 49.3710 after lesion, and the number of RLi/vPAG neurons was reduced from 14427210 in sham rats to 455.5734 in lesioned animals. Periaqueductal neurons of the PAG were not affected by 6-OHDA injection. 6-OHDA solution did not diffuse into the more caudal DR (another component of the A10dc group) and nearby VTA, and dopamine cells of this latter region (strongly implicated in opiate reward) were not observed to be affected. Thus, total number of TH + cells in the VTA was 3848.67125 in sham animals and 3847.37165 cells in lesioned rats. For the DR, 225721 and 215718 TH + neurons were counted in sham and lesioned animals, respectively.
'Anxiety-like' responses and locomotion. After 6-OHDA lesion of the RLi/PAG region, rats did not show emotional 'anxiety-like' disturbances, as revealed by no basal differences between sham and lesioned rats on 'anxiety-like' parameters, as shown in Table 2 . Thus, in the light-dark test, time spent in the light compartment and number of transitions from dark to light (negative indicators of anxiety) were similar in both groups. In the elevated plusmaze tests, the time spent in open arms and the number of transitions to open arms (negative indicators of anxiety) were found to be similar in both groups. Following diazepam treatment, both groups of rats presented a similar anxiolytic profile (Table 2) , and the anxiolytic effect of diazapem was evident by the significant increase in time spent in the light compartment in both groups (t ¼ 3.2, po0.05 vs saline-treated animals), along with the enhancement of percent time on open arms (t ¼ 2.9, po0.05 vs saline-treated). On the other hand, time in the dark compartment (po0.05) and percent time in closed arm (po0.01) were significantly reduced after diazepam in both sham and lesioned rats. Regarding basal locomotion, mean distance travelled (7SEM) in the 10-min open-field test was found to be similar in both groups (sham, 58.576.2 m; lesioned, 61.277.1 m). Conditioned place preference. Habituation of conditioning during the second postconditioning test was not detected (data not shown). Three-way ANOVA revealed an interaction group Â dose Â compartment effect (F(1, 28) ¼ 120.1, po0.01) as well as a dose effect (F(1, 27) ¼ 98, po0.05). Post-hoc analyses revealed that CPP developed in sham rats after 500 mg/kg heroin (po0.01 vs time spent in the salinepaired side), and place preference did not emerge in lesioned rats ( Figure 5 ). Furthermore, sham rats spent significantly more times in the drug-paired side (564760 s) than lesioned rats (180725 s) during postconditioning, while both groups spent similar time in the saline-paired side. Finally, 100 mg/kg heroin did not induce place preference in either sham or lesioned rats, as shown in Figure 5 .
Locomotor sensitization. Regarding heroin's motor sensitization, a group Â dose Â day interaction effect on distance travelled was revealed by ANOVA (F(5, 140) ¼ 7.9, po0.05). Significant group Â dose (F(1, 27) ¼ 19.1, po0.01) and dose effects (F(5, 140) ¼ 21, po0.01) were also revealed by ANOVA. Post-hoc tests revealed that, after 50 mg/kg heroin, distance travelled was significantly enhanced in sham rats during the expression day (day 12) vs day 1 (po0.05), as shown in Figure 5 . No significant heroin's activating effects were observed in the lesioned group after 50 mg/kg heroin, and distance travelled by sham rats during day 12 was significantly higher than that travelled by lesioned animals (po0.05; Figure 5 ). No significant heroin's activating effects were observed in both sham and lesioned groups following 100 mg/kg heroin. These data indicated that heroin's locomotor sensitization developed in sham rats, not in lesioned animals, after 50 mg/kg heroin, and that the highest heroin dose (100 mg/kg) was devoid of effects on locomotor sensitization.
Experiment 4
Systemic heroin and intra-RLi/PAG infusions of D 1 and D 2 receptor antagonists. Two-way ANOVA indicated a significant dose Â compartment effect on time spent in the heroin-paired side during postconditioning after intra-RLi/ PAG eticlopride, D 2 receptor antagonist (F(2, 21) ¼ 210, po0.01), but SCH23390, D 1 receptor antagonist, was devoid of effects, as shown in Figure 6 . Following every SCH23390 dose injection, mean time spent in the heroin-paired side was significantly higher than that in the saline-paired side during postconditioning, indicating the development of place preference (po0.01). However, these differences were affected by eticlopride infusions, as shown in Figure 6 . At 2.6 nmol eticlopride, CPP remained (po0.05 vs salinepaired side) although reduced with respect to 0 dose (po0.05 vs heroin-treated rats with local vehicle). Following 5.3 nmol eticlopride, CPP was abolished and the time spent in the heroin-paired side was significantly reduced vs 0 dose (po0.01 with respect to heroin-treated rats with local vehicle). The results hence indicate that intra-RLi/PAG infusions of eticlopride (but not SCH23390) reduced CPP in a dose-dependent manner. Injections of dopamine receptor antagonists in the vicinity of the RLi/PAG region (central tegmental tract) were devoid of effects on CPP (data not shown), further indicating that conditioned effects were not due to diffusion of dopaminergic antagonists into nearby structures.
DISCUSSION
There is a network of dopamine neurons extending throughout the mesencephalon and adjacent to the VTA-A10 area, which includes the RLi, the PAG, and DR (Hökfelt et al, 1984; Peyron et al, 1995; Hasue and ShammahLagnado, 2002) . The VTA is considered as a critical region for the rewarding and sensitizing properties of drugs of abuse, but in this study the role of extra-VTA dopamine regions (the RLi and PAG) on heroin reward and sensitization has been investigated. The findings indicate that the RLi/PAG dopamine network is involved in the rewarding and sensitizing properties of heroin.
The dopaminergic network of the RLi/PAG region is composed of three types of dopamine neurons: small RLi/ vPAG neurons, periaqueductal neurons of the PAG, and large-size PAG neurons, as reported by others (Hökfelt et al, 1976; Hasue and Shammah-Lagnado, 2002 ). NeuN labelling Values are expressed as percent mean7SEM with respect to a nondopaminergic background signal (commissure superior colliculi). Saline or heroin was administered daily during 3 days (heroin, 500 mg/kg SC). **po0.01 vs corresponding neurons after saline. RLi, rostral linear nucleus; PAG, periaqueductal gray; vPAG, ventral PAG. located in the ventrolateral PAG, and they are multipolar and present abundant arborization. Periaqueductal PAG cells (15 mm in diameter) possess a rounded morphology, and they are mostly located adjacent to the aqueduct of Sylvius. At the most caudal levels of the PAG, large dopamine neurons disappear, and only small dopamine cells can be observed, now including those of the DR, another component of the A10dc group. Many TH + fibers are seen running within the ventrolateral PAG in accordance with Peyron et al (1995) , with regularly spaced synaptic varicosities resembling those observed in other dopaminergic areas such as dorsal striatum, suggesting the existence of a local circuit controlled by dopaminergic neurons. In this context, previous studies have described the presence of scattered dopaminergic neurons in the PAG with relatively short axons, along with larger TH + fibers projecting to different structures such as central amygdaloid nucleus and extended amygdala (Hökfelt et al, 1976; Grove, 1988; Hasue and Shammah-Lagnado, 2002) . The presence of synaptic varicosities in the PAG has also been described (Buma et al, 1992) . Repeated heroin induced enhanced levels of TH (the ratelimiting enzyme in dopamine synthesis) in RLi/vPAG neurons and large PAG neurons, without changes in the expression of PKAa, as measured through TH-ir densitometry and blotting. TH enhancement could also be accounted for by upregulation of this enzyme in other cathecolaminergic neurons (noradrenergic and adrenergic, both TH + and DBH + ), but DBH immunohistochemistry discarded the presence of these cathecolaminergic neurons in the RLi/PAG region. Repeated opiate drug exposure is known to induce biochemical changes in specific brain Figure 5 (a) CPP to heroin in 6-OHDA-lesioned and sham rats. It can be observed that CPP to 500 mg/kg heroin (right) was abolished by the lesion. The dose of 100 mg/kg heroin (left) was devoid of effects in CPP. Mean7SEM of time spent in each compartment during postconditioning, **po0.01 vs time spent by sham rats in saline-paired side; ## po0.01 vs time spent by lesioned rats in the heroin-paired side (Tukey's test). (b) Locomotor sensitization after repeated heroin treatment in 6-OHDA lesioned and sham rats. It can be observed that sham rats presented locomotor sensitization during the expression day (day 12) after 50 mg/kg heroin, but not lesioned animals. The dose of 100 mg/kg heroin was devoid of locomotor effects on both groups. Mean7SEM, *Po0.05 vs day 1 of the same group; # po0.05 vs lesioned rats during the same day (Tukey's test).
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regions thought to mediate the reinforcing actions of drugs, mostly the mesolimbic dopamine system (Wise, 1989; Nestler and Aghajanian, 1997; Nestler, 2001) . Thus, repeated opiate exposure increases VTA TH levels as well as glutamate receptor subunits such as NMDAR1 during the induction phase of sensitization Fitzgerald et al, 1996; Shippenberg and Elmer, 1998; Brodkin et al, 1999) . In the nucleus accumbens, chronic opiate treatment is known to up-regulate activity of the cAMP pathway, increasing levels of PKAa (Terwilliger et al, 1991) . The present study reveals that there are also adaptive biochemical changes in the RLi/ PAG region after a repeated exposure to heroin (3-days), as revealed by TH upregulation, without changes in PKAa expression. These findings are quite similar to those found in the nearby VTA after chronic opiate treatment (BeitnerJohnson and Nestler, 1991) . Considering that PKAa levels were not enhanced after heroin, TH upregulation appears not to be due to activation of the cAMP pathway. TH expression could be upregulated by increase of Ca 2 + entry into dopamine VTA neurons, that activate enzymes such as calcium-calmodulin-dependent-kinase II (CaMKII), or after activation of other kinases such as protein kinase C Williams et al, 2001) . Post-transcriptional mechanisms based on regulation of TH mRNA stability have also been proposed for explaining TH upregulation after opiates (Kumer and Vrana, 1996; Boundy et al, 1998) . These facts deserve further investigation.
After 6-OHDA-induced lesion, this neurotoxin affected every dopamine RLi/PAG neuron except for periaqueductal neurons, indicating that either the toxin did not diffuse into the periaqueductal region (that is unlikely considering the injection area, and the fact that neighboring large TH + neurons were deeply affected) or there is a differential vulnerability to this toxin in TH + cells of the PAG. This latter hypothesis is in line with the fact that dopaminergic neurons of the DR (another part of the A10dc area as mentioned) are known to display a differential vulnerability to toxic agents, as reported by Unguez and Schneider (1988) , who noted a more extensive TH + cell loss in the ventral part of the DR than in the dorsal part in MPTPtreated monkeys. These findings are otherwise consistent with the suggestion that dopamine periaqueductal cells are extensions of the periventricular system Moore and Bloom, 1978) , which lacks the dopamine transporter DAT and is immune to 6-OHDA, whereas the remainder RLi/PAG neurons are extensions of the VTA (Hasue and ShammahLagnado, 2002) , which expresses DAT and hence is vulnerable to the toxin (Kilty et al, 1991; Shimada et al, 1992; Fujita et al, 1993) . In this context, the RLi nucleus is considered as a part of the VTA by some authors (Oades and Halliday, 1987) . The neurotoxic effect of 6-OHDA was restricted to the RLi/PAG region because the VTA and DR areas were not affected, further reinforcing that observed functional effects were caused by the selective disruption of the dopaminergic network of the RLi/PAG region.
Regarding these functional effects, 6-OHDA infusions into the RLi/PAG region did not alter basal locomotion and 'anxiety-like' responses, discarding that possible motor or emotional deficits after lesion could mask or interfere functional results in heroin-treated lesioned rats. However, dopamine neurons of the RLi/PAG region appear to mediate heroin-induced reward critically because CPP to 500 mg/kg heroin was abolished following dopaminergic lesion of the RLi/PAG region. CPP is widely used for discerning positive incentive-motivational effects of drugs of abuse, and it is a Pavlovian test based on the conditioned association between certain environment and the incentive actions of the drug (Koob et al, 1986; Bardo et al, 1995; Tzschentke, 1998) . The incentive value of heroin, an important factor for the development of addiction (Robinson and Berridge, 1993; Nestler, 2001) , can thus be estimated through this test. On the other hand, the data suggest that D 2 dopamine receptors (but not D 1 ) within RLi/PAG seem to participate in the rewarding effects of heroin, since their blockade with eticlopride (a very selective D 2 antagonist; Seeman and Van Tol, 1994 ) reduced CPP to heroin in a dose-dependent manner. D 2 dopamine receptors are known to be expressed by PAG neurons (Bouthenet et al, 1987; Martin-Ruiz et al, 2001 ), but the presence and distribution of D 1 dopamine receptor in neurons of RLi/PAG has not been described so far. The present study indicates that a population of RLi/ PAG neurons expressing D 2 dopamine receptors are involved in the modulation of heroin's rewarding effects. The mechanism of action of eticlopride is difficult to explain. Considering that D 2 receptors expressed by midbrain DA neurons (substantia nigra and VTA) are mostly inhibitory autoreceptors located on dendrites and perikarya (Bouthenet et al, 1987) , and assuming a similar localization in the RLi/PAG (extra-VTA extension), eticlopride would be expected to enhance dopaminergic release, hence facilitating dopaminergic activity within the RLi/PAG region. In this case, functional effects should be opposite to those observed following RLi/PAG dopamine lesion. However, these receptors could be also heteroceptors located on nondopaminergic neurons, and D 2 -mediated effects could be indirect through a modification of other neurotransmitter systems such as the midbrain serotonergic one. Thus, it is known that dopamine depolarizes midbrain serotonin neurons by an action on DA D 2 receptors (Haj-Dahmane and Shen, 2000) , and systemic quinpirole (D 2 agonist) enhances serotonin release in the DR (Martin-Ruiz et al, 2001) , and it has been proposed that DA D 2 receptors outside the DR (likely on PAG GABA neurons) control serotonergic activity in this nucleus (Martin-Ruiz et al, 2001) . Furthermore, DR serotonin neurotransmission is involved in CPP, because local infusions of the 5-HT 1 agonist 8-OH-DPAT into the DR produce CPP (Fletcher et al, 1993) . It can be hypothesized that an eticlopridemediated indirect inhibition of serotonin neurons of the DR could disrupt CPP to heroin. It must be taken into account that infusions of dopaminergic antagonists were made unilaterally, and it is likely that the effects would become more robust if injections were made bilaterally.
Heroin's locomotor sensitization was blocked after dopamine depletion within the RLi/PAG region, at the 50 mg/kg heroin dose. A higher dose (100 mg/kg) was devoid of effect on sensitization, which could be accounted for by the emergence of sedative effects of the opiate drug. This fact is otherwise in accordance with previous findings indicating that locomotor sensitization is better discerned following repeated low heroin doses (o100 mg/kg), because higher doses are known to induce hypolocomotion and catalepsy (Marinelli et al, 1998; Pontieri et al, 2001 ). Locomotor sensitization is the enduring enhancement in the motor stimulant effects elicited by repeated drug administration (Stewart and Badiani, 1993; Vanderschuren and Kalivas, 2000; Nestler, 2001) , and neural adaptations that result in sensitization in animal models are likely the same that result in some forms of addictive behavior in humans (Robinson and Berridge, 1993; Carlezon et al, 1997; Nestler and Aghajanian, 1997; Nestler, 2001) . Locomotor sensitization has been hypothesized to be a manifestation of enhanced motivational ('wanting') properties of drugs, or of the neural adaptations underlying drug craving (Robinson and Berridge, 1993) . The dopaminergic network of the RLi/PAG region hence seems to be involved in the development or induction of locomotor sensitization to opiates.
As explained before, dopamine neurons of the RLi and PAG project onto structures such as central amygdaloid nucleus, bed nucleus of the stria terminalis, sublenticular extended amygdala, and substantia innominata (Ottersen, 1981; Grove, 1988; Hasue and Shammah-Lagnado, 2002) . Dopaminergic activity in some of these areas has been reported to be involved in rewarding and sensitizing properties of drugs of abuse such as opiates (Wise, 1989; Caine et al, 1995; Di Chiara et al, 1999; Nestler, 2001) . The data of the present study suggest that the dopaminergic network of the RLi/PAG region would also participate in these processes. Besides, considering a possible dopamine/ serotonin interaction for explaining the effect of eticlopride on CPP, a link between the RLi/PAG region and serotonergic DR activity on opiate reward cannot be ruled out. To sum up, it seems that dopaminergic areas adjacent to the VTA such as RLi and PAG play a similar role as that of the VTA in the induction of opiate sensitization and reward. In this respect, Hasue and Shammah-Lagnado (2002) have proposed that, since RLi, and PAG TH + afferents course in the VTA and medial forebrain bundle to innervate the amygdala (Vertes, 1991) , the substantial decrease in amygdala dopamine content produced by VTA lesions should be ascribed to interruption of both A10, RLi and A10dc amygdalopetal projections. The fact that CPP was blocked after lesion of the RLi/PAG region while VTA remained intact suggests that the mesencephalic dopamine network (including VTA and RLi/PAG) acts as an integrated neural system whose disruption exerts a profound effect on heroin effects. To sum up, the RLi/PAG region should be included as another critical dopaminergic region for the induction of heroin's sensitization and reward, apart from the VTA. D 2 dopamine receptors located on neurons of the RLi/PAG region seem to participate in heroin's reward effects.
